⌘K

Login Start Free

Home/Filings/4/0001127602-22-025832

4//SEC Filing

Douglas Robert Andrew 4

Accession 0001127602-22-025832

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 5:40 PM ET

Size

12.6 KB

Accession

0001127602-22-025832

Insider Transaction Report

Form 4

Period: 2022-11-15

Douglas Robert Andrew

COO Asia Pacific

Transactions

Exercise/Conversion
ResMed Common Stock
2022-11-15$58.24/sh+16,888$983,557→ 51,466 total
Exercise/Conversion
ResMed Common Stock Options
2022-11-15−1,144→ 16,888 total
Exercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (1,144 underlying)
Exercise/Conversion
ResMed Common Stock
2022-11-15$58.24/sh+1,144$66,627→ 34,578 total
Sale
ResMed Common Stock
2022-11-15$222.07/sh−11,280$2,504,939→ 40,186 total
Exercise/Conversion
ResMed Common Stock Options
2022-11-15−16,888→ 0 total
Exercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (16,888 underlying)

Holdings

ResMed Common Stock
(indirect: By Trust)
227,708

Footnotes (3)

[F1]The transaction was conducted under a Rule 10b5-1 plan.
[F2]This transaction was executed in multiple trades at prices ranging from $221.77 $223.56. The price reported above reflects the weighted average sale price.
[F3]Represents date options first became exercisable. Options vest 1/3 per year.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001352232

Filing Metadata

Form type: 4
Filed: Nov 15, 7:00 PM ET
Accepted: Nov 16, 5:40 PM ET
Size: 12.6 KB

View on SEC.gov